Streetwise Articles

Cancer Fighter Sesen Bio Leaps 13% on FDA Decision
Source: Streetwise Reports  (5/21/19)
Shares of this biotech stock were up significantly at the close of trading on Tuesday, May 21, attributed to the announcement of some good news from the FDA. More >

Firm Takes Steps to Launch Recreational Cannabis Brand
Source: Streetwise Reports  (5/17/19)
The company continues to make preparations while it awaits receipt of a sales license. More >

Harrow Comes Out of Allergan Lawsuit Unscathed
Source: Daniel Carlson for Streetwise Reports  (5/17/19)
Sector expert Daniel Carlson offers his take on the recent jury decision, calling it "very positive." More >

Why Did ImmunoGen Plummet 32%?
Source: Streetwise Reports  (5/16/19)
This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday. More >

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming
Source: Streetwise Reports  (5/15/19)
A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. More >

FDA Approval of Antibiotic for Bacterial Pneumonia Expected in Late Summer
Source: Streetwise Reports  (5/15/19)
An update on this biopharma's two lead drug candidate programs was provided in an H.C. Wainwright report. More >

Biopharma Releases Preliminary Data from Alcoholic Hepatitis Study
Source: Streetwise Reports  (5/10/19)
The results compare favorably to those of the historical control group. More >

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million
Source: Streetwise Reports  (5/8/19)
The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. More >

Price Target Raised on Biopharma Ahead of Leukemia Trial Update
Source: Streetwise Reports  (5/8/19)
The expected data and their implications were addressed in a ROTH Capital Partners report. More >

Shares of Plant-Based Meat Company Spike 53% (and It's Not Beyond Meat)
Source: Streetwise Reports  (5/6/19)
This small-cap nutrascience stock hit a new 52-week high on May 6th, extending a run that has the stock up 147% over a five-day period. More >

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial
Source: Streetwise Reports  (5/1/19)
A study update and the next steps to advance the therapeutic were covered in a ROTH Capital Partners report. More >

Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech
Source: Streetwise Reports  (5/1/19)
Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report. More >

Firm's AR E-Commerce Solutions to Be Marketed, Sold to Dispensaries
Source: Streetwise Reports  (4/29/19)
With the signing of a reseller agreement, the tech firm continues to penetrate Canada's burgeoning legal cannabis industry. More >

'Undervalued' Biopharma Features Robust Pipeline, Future Upside
Source: Streetwise Reports  (4/24/19)
The case for investing in this company was made in an H.C. Wainwright & Co. report. More >

Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool
Source: Streetwise Reports  (4/24/19)
This effort is one way the company can innovatively offer patients care. More >

Peter Epstein

California Gold Mining Full Speed Ahead in Hemp
Source: Peter Epstein for Streetwise Reports  (4/18/19)
Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market. More >

Health Technology Firm Aims to Extend Reach into Global Medical Cannabis Industry
Source: Streetwise Reports  (4/17/19)
This company is targeting geographies where the cannabis market is growing rapidly. More >

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target
Source: Streetwise Reports  (4/17/19)
An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. More >

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial
Source: Streetwise Reports  (4/17/19)
Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. More >

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease
Source: Streetwise Reports  (4/10/19)
Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. More >

Augmented Reality Firm Moves into Medical Devices Arena
Source: Streetwise Reports  (4/9/19)
This technology company continues to diversify the end markets for its e-commerce platform. More >

Canadian Tech Firm Secures Largest Contract to Date
Source: Streetwise Reports  (4/6/19)
The new client, in the U.S., is a state governmental agency. More >

Biotech Achieves Development Milestone for Blue Light Imaging System
Source: Streetwise Reports  (4/5/19)
The surgical imaging firm continues to advance its first medical device toward commercialization. More >

Canadian Life Sciences Firm Seeks Collaborative Cannabis Partner
Source: Streetwise Reports  (4/5/19)
This represents the company's expansion into another business area. More >

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies
Source: Streetwise Reports  (4/3/19)
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. More >

Showing Results: 1 to 25 of 1075 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe